
Lymphohaematopoietic Growth Factors in Cancer Therapy II
Versandkostenfrei!
Versandfertig in 1-2 Wochen
77,99 €
inkl. MwSt.
PAYBACK Punkte
39 °P sammeln!
Contents: Introduction and OverviewLymphopoietic Growth Factors: Pathophysiology of T-CellMediated Shock Induced by Bacterial Superantigens - NaturalKiller Cells and Interleukin-2-Activated Killer Cells -TumourImmunogenicity Induced by Exogenous Interleukins -Cytokine Gene Therapy of Cancer - Analysis of T-CellReceptor Variability in Tumour Infiltrating Lymphocytes -Clinical Studies with Interleukin-2: An Overview - ClinicalTrials with Local Administration of Lymphopoietic GrowthFactors - Clinical Trials with Interlaukin-2. The RomeExperience.Haematopoietic Growth Factors: Lymphohaematopoietic...
Contents: Introduction and Overview
Lymphopoietic Growth Factors: Pathophysiology of T-Cell
Mediated Shock Induced by Bacterial Superantigens - Natural
Killer Cells and Interleukin-2-Activated Killer Cells -
TumourImmunogenicity Induced by Exogenous Interleukins -
Cytokine Gene Therapy of Cancer - Analysis of T-Cell
Receptor Variability in Tumour Infiltrating Lymphocytes -
Clinical Studies with Interleukin-2: An Overview - Clinical
Trials with Local Administration of Lymphopoietic Growth
Factors - Clinical Trials with Interlaukin-2. The Rome
Experience.
Haematopoietic Growth Factors: Lymphohaematopoietic Growth
Factor Use in Lung Cancer Patients - Clinical Trials with
Haematopoietic Growth Factors and Peripheral Blood Stem
Cells
Lymphopoietic Growth Factors: Pathophysiology of T-Cell
Mediated Shock Induced by Bacterial Superantigens - Natural
Killer Cells and Interleukin-2-Activated Killer Cells -
TumourImmunogenicity Induced by Exogenous Interleukins -
Cytokine Gene Therapy of Cancer - Analysis of T-Cell
Receptor Variability in Tumour Infiltrating Lymphocytes -
Clinical Studies with Interleukin-2: An Overview - Clinical
Trials with Local Administration of Lymphopoietic Growth
Factors - Clinical Trials with Interlaukin-2. The Rome
Experience.
Haematopoietic Growth Factors: Lymphohaematopoietic Growth
Factor Use in Lung Cancer Patients - Clinical Trials with
Haematopoietic Growth Factors and Peripheral Blood Stem
Cells